Triple-negative breast cancer (TNBC) is defined by lacking estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) [2]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.